Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on Insider Sale: Chairperson & CEO of $ZLAB Sells 7,072 Shares - Nasdaq

Insider Sale: Chairperson & CEO of $ZLAB Sells 7,072 Shares  Nasdaq

Insider Sale: Chairperson & CEO of $ZLAB Sells 7,072 Shares - Nasdaq

Click here to get full coverage on Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33%  simplywall.st

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st

Click here to get full coverage on Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis - Yahoo Finance

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis  Yahoo Finance

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis - Yahoo Finance

Click here to get full coverage on Breakthrough Phase 3 Results: First FGFR2b Drug Shows Major Survival Benefit in Advanced Gastric Cancer - Stock Titan

Breakthrough Phase 3 Results: First FGFR2b Drug Shows Major Survival Benefit in Advanced Gastric Cancer  Stock Titan

Breakthrough Phase 3 Results: First FGFR2b Drug Shows Major Survival Benefit in Advanced Gastric Cancer - Stock Titan

Click here to get full coverage on ZLAB Stock: Leerink Partners Raises Price Target for Zai Lab to $75 | ZLAB Stock News - GuruFocus

ZLAB Stock: Leerink Partners Raises Price Target for Zai Lab to $75 | ZLAB Stock News  GuruFocus

ZLAB Stock: Leerink Partners Raises Price Target for Zai Lab to $75 | ZLAB Stock News - GuruFocus

Click here to get full coverage on Zai Lab (ZLAB) chief legal officer sells $212k in shares - Investing.com

Zai Lab (ZLAB) chief legal officer sells $212k in shares  Investing.com

Zai Lab (ZLAB) chief legal officer sells $212k in shares - Investing.com

Click here to get full coverage on When (ZLAB) Moves Investors should Listen - news.stocktradersdaily.com

When (ZLAB) Moves Investors should Listen  news.stocktradersdaily.com

When (ZLAB) Moves Investors should Listen - news.stocktradersdaily.com

Click here to get full coverage on ‘I’m more humble now’: Joe Zlab shares his Jan. 6 experience after Trump pardon - MyNorthwest.com

‘I’m more humble now’: Joe Zlab shares his Jan. 6 experience after Trump pardon  MyNorthwest.com

‘I’m more humble now’: Joe Zlab shares his Jan. 6 experience after Trump pardon - MyNorthwest.com

Click here to get full coverage on Zai Lab (ZLAB) Shares Soar 5.23% on Positive Earnings, Institutional Buying - AInvest

Zai Lab (ZLAB) Shares Soar 5.23% on Positive Earnings, Institutional Buying  AInvest

Zai Lab (ZLAB) Shares Soar 5.23% on Positive Earnings, Institutional Buying - AInvest

Click here to get full coverage on ZLab ZJoins Mini Review: The Missing Link - Vaping360

ZLab ZJoins Mini Review: The Missing Link  Vaping360

ZLab ZJoins Mini Review: The Missing Link - Vaping360

Click here to get full coverage on Zai Lab Limited Is Well Positioned For Long-Term Growth - Seeking Alpha

Zai Lab Limited Is Well Positioned For Long-Term Growth  Seeking Alpha

Zai Lab Limited Is Well Positioned For Long-Term Growth - Seeking Alpha

Click here to get full coverage on ZLAB stock hits 52-week high at $39.81 amid robust growth - Investing.com

ZLAB stock hits 52-week high at $39.81 amid robust growth  Investing.com

ZLAB stock hits 52-week high at $39.81 amid robust growth - Investing.com

Click here to get full coverage on Breakthrough: Zai Lab's New Antibody Drug Blocks Both Inflammation and Itch in Atopic Dermatitis for Over 2 Months - Stock Titan

Breakthrough: Zai Lab's New Antibody Drug Blocks Both Inflammation and Itch in Atopic Dermatitis for Over 2 Months  Stock Titan

Breakthrough: Zai Lab's New Antibody Drug Blocks Both Inflammation and Itch in Atopic Dermatitis for Over 2 Months - Stock Titan

Click here to get full coverage on Victor Shelton on ZLAB’s Journey: Innovation, Customization, and the Future of Vaping - Vaping360

Victor Shelton on ZLAB’s Journey: Innovation, Customization, and the Future of Vaping  Vaping360

Victor Shelton on ZLAB’s Journey: Innovation, Customization, and the Future of Vaping - Vaping360

Click here to get full coverage on Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? - Yahoo Finance

Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025?  Yahoo Finance

Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? - Yahoo Finance

Click here to get full coverage on Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st

Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them.  simplywall.st

Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st

Click here to get full coverage on Zai Lab Limited: Banking On Chinese Pharma Growth (NASDAQ:ZLAB) - Seeking Alpha

Zai Lab Limited: Banking On Chinese Pharma Growth (NASDAQ:ZLAB)  Seeking Alpha

Zai Lab Limited: Banking On Chinese Pharma Growth (NASDAQ:ZLAB) - Seeking Alpha

Click here to get full coverage on Zai Lab Limited (NASDAQ:ZLAB) Just Released Its Annual Results And Analysts Are Updating Their Estimates - Yahoo Finance

Zai Lab Limited (NASDAQ:ZLAB) Just Released Its Annual Results And Analysts Are Updating Their Estimates  Yahoo Finance

Zai Lab Limited (NASDAQ:ZLAB) Just Released Its Annual Results And Analysts Are Updating Their Estimates - Yahoo Finance

Click here to get full coverage on Insider Sell: William Lis Sells 13,814 Shares of Zai Lab Ltd (ZLAB) - GuruFocus

Insider Sell: William Lis Sells 13,814 Shares of Zai Lab Ltd (ZLAB)  GuruFocus

Insider Sell: William Lis Sells 13,814 Shares of Zai Lab Ltd (ZLAB) - GuruFocus

Click here to get full coverage on Zai Lab Q1 2025 Earnings Preview: Key Financial Results Coming May 8 - Stock Titan

Zai Lab Q1 2025 Earnings Preview: Key Financial Results Coming May 8  Stock Titan

Zai Lab Q1 2025 Earnings Preview: Key Financial Results Coming May 8 - Stock Titan

Click here to get full coverage on Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout - Insider Monkey

Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout  Insider Monkey

Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout - Insider Monkey

Click here to get full coverage on Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts - Insider Monkey

Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts  Insider Monkey

Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts - Insider Monkey

Click here to get full coverage on Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - Nasdaq

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say  Nasdaq

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - Nasdaq

Click here to get full coverage on Phase 1 Trial Shows 79% Response Rate for Zai Lab Lung Cancer Drug ZL-1310 | ZLAB Stock News - Stock Titan

Phase 1 Trial Shows 79% Response Rate for Zai Lab Lung Cancer Drug ZL-1310 | ZLAB Stock News  Stock Titan

Phase 1 Trial Shows 79% Response Rate for Zai Lab Lung Cancer Drug ZL-1310 | ZLAB Stock News - Stock Titan

Click here to get full coverage on Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial - Insider Monkey

Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial  Insider Monkey

Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial - Insider Monkey

Click here to get full coverage on Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025 - Business Wire

Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025  Business Wire

Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025 - Business Wire

Click here to get full coverage on Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB) - Seeking Alpha

Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB)  Seeking Alpha

Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB) - Seeking Alpha

Click here to get full coverage on Is Zai Lab Limited (ZLAB) the Best Performing Mid Cap Stock to Buy According to Analysts? - Insider Monkey

Is Zai Lab Limited (ZLAB) the Best Performing Mid Cap Stock to Buy According to Analysts?  Insider Monkey

Is Zai Lab Limited (ZLAB) the Best Performing Mid Cap Stock to Buy According to Analysts? - Insider Monkey

Click here to get full coverage on Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLA - GuruFocus

Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLA  GuruFocus

Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLA - GuruFocus

Click here to get full coverage on Biotech Stock In A Base As Sales Grow 66% And Losses Improve - Investor's Business Daily

Biotech Stock In A Base As Sales Grow 66% And Losses Improve  Investor's Business Daily

Biotech Stock In A Base As Sales Grow 66% And Losses Improve - Investor's Business Daily

Click here to get full coverage on 11 Best Breakout Stocks to Buy According to Analysts - Insider Monkey

11 Best Breakout Stocks to Buy According to Analysts  Insider Monkey

11 Best Breakout Stocks to Buy According to Analysts - Insider Monkey

Click here to get full coverage on Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025 | ZLAB Stock News - GuruFocus

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025 | ZLAB Stock News  GuruFocus

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025 | ZLAB Stock News - GuruFocus

Click here to get full coverage on Press Release: ZLab to Unveil Innovative ZLand System at NEC Birmingham Expo - Vaping360

Press Release: ZLab to Unveil Innovative ZLand System at NEC Birmingham Expo  Vaping360

Press Release: ZLab to Unveil Innovative ZLand System at NEC Birmingham Expo - Vaping360

Click here to get full coverage on Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates  Business Wire

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire

Click here to get full coverage on Breakthrough: New Treatment Extends Pancreatic Cancer Survival by 16.2 Months in Landmark Phase 3 Trial - Stock Titan

Breakthrough: New Treatment Extends Pancreatic Cancer Survival by 16.2 Months in Landmark Phase 3 Trial  Stock Titan

Breakthrough: New Treatment Extends Pancreatic Cancer Survival by 16.2 Months in Landmark Phase 3 Trial - Stock Titan

Click here to get full coverage on Press Release: Explore ZLab’s Flavor Innovation at Fiera Roma - Vaping360

Press Release: Explore ZLab’s Flavor Innovation at Fiera Roma  Vaping360

Press Release: Explore ZLab’s Flavor Innovation at Fiera Roma - Vaping360

Click here to get full coverage on Zai Lab Announces Pricing of Public Offering of American Depositary Shares - Business Wire

Zai Lab Announces Pricing of Public Offering of American Depositary Shares  Business Wire

Zai Lab Announces Pricing of Public Offering of American Depositary Shares - Business Wire

Click here to get full coverage on Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates - Business Wire

Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates  Business Wire

Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates - Business Wire

Click here to get full coverage on Press Release: Join Us at Intertabac 2024 for ZLab’s Highly Anticipated Launch! - Vaping360

Press Release: Join Us at Intertabac 2024 for ZLab’s Highly Anticipated Launch!  Vaping360

Press Release: Join Us at Intertabac 2024 for ZLab’s Highly Anticipated Launch! - Vaping360

Click here to get full coverage on Ropes & Gray Advises Zai Lab on $200 Million Secondary Offering - Ropes & Gray LLP

Ropes & Gray Advises Zai Lab on $200 Million Secondary Offering  Ropes & Gray LLP

Ropes & Gray Advises Zai Lab on $200 Million Secondary Offering - Ropes & Gray LLP

Click here to get full coverage on Zai Lab stock price target raised to $75 from $73 at Leerink Partners By Investing.com - Investing.com South Africa

Zai Lab stock price target raised to $75 from $73 at Leerink Partners By Investing.com  Investing.com South Africa

Zai Lab stock price target raised to $75 from $73 at Leerink Partners By Investing.com - Investing.com South Africa

Click here to get full coverage on Press Release: ZLab Brings Customizable Vaping to Moscow - Vaping360

Press Release: ZLab Brings Customizable Vaping to Moscow  Vaping360

Press Release: ZLab Brings Customizable Vaping to Moscow - Vaping360

Click here to get full coverage on Exploring the ZLab Z-Ecosystem: Versatility Reimagined! - Vaping360

Exploring the ZLab Z-Ecosystem: Versatility Reimagined!  Vaping360

Exploring the ZLab Z-Ecosystem: Versatility Reimagined! - Vaping360

Click here to get full coverage on Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting - Business Wire

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting  Business Wire

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting - Business Wire

Click here to get full coverage on ZLand & ZColors Review: Might Be the Best Ever! - Vaping360

ZLand & ZColors Review: Might Be the Best Ever!  Vaping360

ZLand & ZColors Review: Might Be the Best Ever! - Vaping360

Click here to get full coverage on Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire

Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates  Business Wire

Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire

Click here to get full coverage on Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | ZLAB Stock News - GuruFocus

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | ZLAB Stock News  GuruFocus

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | ZLAB Stock News - GuruFocus

Click here to get full coverage on Zai Lab Announces Participation in Investor Conferences in March 2025 - Business Wire

Zai Lab Announces Participation in Investor Conferences in March 2025  Business Wire

Zai Lab Announces Participation in Investor Conferences in March 2025 - Business Wire

Click here to get full coverage on Press Release: Discover the Future of Vaping with ZLab in Pretoria! - Vaping360

Press Release: Discover the Future of Vaping with ZLab in Pretoria!  Vaping360

Press Release: Discover the Future of Vaping with ZLab in Pretoria! - Vaping360

Click here to get full coverage on Zai Lab earnings beat by $0.42, revenue fell short of estimates - Investing.com

Zai Lab earnings beat by $0.42, revenue fell short of estimates  Investing.com

Zai Lab earnings beat by $0.42, revenue fell short of estimates - Investing.com

Click here to get full coverage on Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate - Business Wire

Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate  Business Wire

Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate - Business Wire

Click here to get full coverage on Press Release: ZLab Breaks Through with the Next Generation of Vapes - Vaping360

Press Release: ZLab Breaks Through with the Next Generation of Vapes  Vaping360

Press Release: ZLab Breaks Through with the Next Generation of Vapes - Vaping360

Click here to get full coverage on Citi Trims Zai Lab (ZLAB.US) TP to US$66, Rating Buy - AASTOCKS.com

Citi Trims Zai Lab (ZLAB.US) TP to US$66, Rating Buy  AASTOCKS.com

Citi Trims Zai Lab (ZLAB.US) TP to US$66, Rating Buy - AASTOCKS.com

Click here to get full coverage on Zai Lab’s Growth Strategy And China’s Policy Reforms Set Path For Profitability By 2025 - Seeking Alpha

Zai Lab’s Growth Strategy And China’s Policy Reforms Set Path For Profitability By 2025  Seeking Alpha

Zai Lab’s Growth Strategy And China’s Policy Reforms Set Path For Profitability By 2025 - Seeking Alpha

Click here to get full coverage on Zai Lab Announces Participation in Investor Conferences in June 2025 - Yahoo Finance

Zai Lab Announces Participation in Investor Conferences in June 2025  Yahoo Finance

Zai Lab Ltd (ZLAB)

Price Chart

Key Statistics

Technicals

About ZLAB

Latest News

Insider Sale: Chairperson & CEO of $ZLAB Sells 7,072 Shares - Nasdaq

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers